Engaging older patients in cardiovascular research: observational analysis of the ICON-1 study

Hannah Sinclair, Jonathan A Batty, Weiliang Qiu, Vijay Kunadian, Hannah Sinclair, Jonathan A Batty, Weiliang Qiu, Vijay Kunadian

Abstract

Background: As a consequence of population ageing, the number of older patients presenting with acute coronary syndrome (ACS) is increasing. The historical underrepresentation of older patients in many pivotal ACS clinical trials undermines the practice of evidence-based medicine in this high-risk cohort. This study evaluates the feasibility of recruitment of older patients to a longitudinal, clinical study.

Methods: The study to Improve Cardiovascular Outcomes in high-risk patieNts with ACS (ICON-1) is an observational, prospective cohort study investigating predictors of poor outcome in older patients with ACS. All patients aged ≥75 years, referred to a tertiary cardiovascular centre in the North East of England for coronary angiography with a view to urgent percutaneous coronary intervention, were screened for inclusion. A screening log was prospectively maintained, and a detailed analysis was performed to identify the factors associated with recruitment and non-recruitment to ICON-1.

Results: Of the 629 patients screened over 34 months, 457 (72.7%) satisfied the a priori-defined study inclusion/exclusion criteria. Of those eligible to participate, 300 (68.5%) provided informed consent and were recruited to the study; 59 (13.5%) were unable to consent due to a lack of capacity or limitations in communication, and 79 patients (18.0%) declined to participate in the study. Those lacking adequate capacity to consent were older than those able to provide informed consent (83.0±4.7 vs 81.0±4.7 years, p=0.002). Women were more likely to decline than men (25.1% vs 10.0%, p<0.001).

Conclusions: The recruitment of patients was robust, comparing favourably to previous longitudinal studies within this age group. Although enrolling older people to research remains challenging, this cohort is enthusiastic to participate. The contribution of older patients must not be ignored, particularly in the setting of an ever-ageing population, in whom cardiovascular disease burden is high.

Trial registration number: NCT01933581; Pre-results.

Keywords: AGEING; CORONARY ARTERY DISEASE.

Figures

Figure 1
Figure 1
Flow diagram of patients screened for inclusion in ICON-1. ACS, acute coronary syndrome; CABG, coronary artery bypass graft; PCI, percutaneous coronary intervention.

References

    1. Office for National Statistics. 2011 Census: population and household estimates for England and Wales. London, UK: Office for National Statistics, 2012.
    1. Myocardial Ischaemia National Audit Project. UK Myocardial Ischaemia National Audit Project (MINAP) Annual Public Report (2011–12) London, UK, 2012.
    1. British Cardiovascular Intervention Society. National Audit of Percutaneous Coronary Interventional Procedures: Annual Public Report (January 2012—December 2012) London, UK, 2014.
    1. Avezum A, Makdisse M, Spencer F et al. . Impact of age on management and outcome of acute coronary syndrome: observations from the Global Registry of Acute Coronary Events (GRACE). Am Heart J 2005;149:67–73. 10.1016/j.ahj.2004.06.003
    1. Lee PY, Alexander KP, Hammill BG et al. . Representation of elderly persons and women in published randomized trials of acute coronary syndromes. JAMA 2001;286:708–13. 10.1001/jama.286.6.708
    1. Davies K, Collerton JC, Jagger C et al. . Engaging the oldest old in research: lessons from the Newcastle 85+ study. BMC Geriatr 2010;10:64 10.1186/1471-2318-10-64
    1. von Elm E, Altman DG, Egger M et al. . The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007;18:800–4. 10.1097/EDE.0b013e3181577654
    1. de Belder A, de la Torre Hernandez JM, Lopez-Palop R et al. . A prospective randomized trial of everolimus-eluting stents versus bare-metal stents in octogenarians: the XIMA Trial (Xience or Vision Stents for the Management of Angina in the Elderly). J Am Coll Cardiol 2014;63:1371–5. 10.1016/j.jacc.2013.10.053
    1. Galasso G, De Servi S, Savonitto S et al. . Effect of an invasive strategy on outcome in patients ≥75 years of age with non-ST-elevation acute coronary syndrome. Am J Cardiol 2015;115:576–80. 10.1016/j.amjcard.2014.12.005
    1. Liu Y, Gao L, Xue Q et al. . Impact of renal dysfunction on long-term outcomes of elderly patients with acute coronary syndrome: a longitudinal, prospective observational study. BMC Nephrol 2014;15:78 10.1186/1471-2369-15-78
    1. Showkathali R, Boston-Griffiths E, Parker M et al. . Should primary percutaneous coronary intervention be the routine reperfusion strategy in octogenarians presenting with ST elevation myocardial infarction? J Cardiovasc Med (Hagerstown) 2014;15:53–9. 10.2459/JCM.0b013e3283649978
    1. Savonitto S, Cavallini C, Petronio AS et al. . Early aggressive versus initially conservative treatment in elderly patients with non-ST-segment elevation acute coronary syndrome: a randomized controlled trial. JACC Cardiovasc Interv 2012;5:906–16. 10.1016/j.jcin.2012.06.008
    1. Tegn N, Abdelnoor M, Aaberge L et al. . Invasive versus conservative strategy in patients aged 80 years or older with non-ST-elevation myocardial infarction or unstable angina pectoris (After Eighty Study): an open-label randomised controlled trial. Lancet 2016;387:1057–65.
    1. Sinclair H, Kunadian V. Coronary revascularisation in older patients with non-ST elevation acute coronary syndromes. Heart 2016;102:416–24. 10.1136/heartjnl-2015-307859
    1. Tolmie EP, Mungall MM, Louden G et al. . Understanding why older people participate in clinical trials: the experience of the Scottish PROSPER participants. Age Ageing 2004;33:374–8. 10.1093/ageing/afh109
    1. Ory MG, Lipman PD, Karlen PL et al. . Recruitment of older participants in frailty/injury prevention studies. Prev Sci 2002;3:1–22. 10.1023/A:1014610325059
    1. Duffy LM, Wyble SJ, Wilson B et al. . Obtaining geriatric patient consent. J Gerontol Nurs 1989;15:21–4. 10.3928/0098-9134-19890101-06
    1. DeLuca SA, Korcuska LA, Oberstar BH et al. . Are we promoting true informed consent in cardiovascular clinical trials? J Cardiovasc Nurs 1995;9:54–61. 10.1097/00005082-199504000-00007
    1. Diener L, Hugonot-Diener L, Alvino S et al. , European Forum for Good Clinical Practice Geriatric Medicine Working Party. Guidance synthesis. Medical research for and with older people in Europe: proposed ethical guidance for good clinical practice: ethical considerations. J Nutr Health Aging 2013;17:625–7.
    1. Collerton J, Davies K, Jagger C et al. . Health and disease in 85-year-olds: baseline findings from the Newcastle 85+ cohort study. BMJ 2009;339:b4904 10.1136/bmj.b4904
    1. McMurdo ME, Roberts H, Parker S et al. . Improving recruitment of older people to research through good practice. Age Ageing 2011;40:659–65. 10.1093/ageing/afr115
    1. Kemeny MM, Peterson BL, Kornblith AB et al. . Barriers to clinical trial participation by older women with breast cancer. J Clin Oncol 2003;21:2268–75. 10.1200/JCO.2003.09.124
    1. Javid SH, Unger JM, Gralow JR et al. . A prospective analysis of the influence of older age on physician and patient decision-making when considering enrollment in breast cancer clinical trials (SWOG S0316). Oncologist 2012;17:1180–90. 10.1634/theoncologist.2011-0384
    1. Crome P, Cherubini A, Oristrell J. The PREDICT (increasing the participation of the elderly in clinical trials) study: the charter and beyond. Expert Rev Clin Pharmacol 2014;7: 457–68. 10.1586/17512433.2014.922864
    1. Hertogh CM. Development of a charter for older people in clinical trials: PREDICT. Tijdschr Gerontol Geriatr 2009;40: 180–3. 10.1007/BF03079586

Source: PubMed

Sponsoren und Mitarbeiter

Krankheiten

Drogeninterventionen

3
Abonnieren